Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 6, 2013
Reporting Period: Second fiscal quarter ended June 30, 2013
This filing serves as a notification that the company issued a press release announcing its second-quarter 2013 financial results. The detailed results are contained in Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The provided text is a cover document for the Form 8-K and does not contain specific financial data points. The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are located in the referenced press release (Exhibit 99.1), which is not included in the input text.
Material Changes
No material changes or comparative financial data are disclosed within the body of this specific filing text. The document solely references the issuance of the quarterly results announcement.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the issuance of a press release regarding Q2 2013 results but does not include the content of that commentary.
Legal Disclaimer: The information in this Current Report is furnished pursuant to Item 2.02 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. It is not subject to the liabilities of that section and shall not be incorporated by reference into any other filing under the Securities Act or Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 6, 2013) for actual revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter performance trends in the full press release.
- Check for any forward-looking statements or guidance updates included in the referenced exhibit.
- Confirm the company's liquidity position and debt obligations as detailed in the full financial results.